Abstract
In order to evaluate the efficacy of combined immunochemotherapy with mitomycin-C, tegafur, PSK and/or OK-432 as an adjunct for curatively resected gastric cancer, a prospective randomized controlled study using the envelope method was performed, in which 266 institutions from around Japan participated. The 3 year survival rates for all cases, and for ps(+)·n(+) cases, were insignificantly higher in the immunochemotherapy groups receiving PSK and/or OK-432 than in the control group. However, because 28.2 per cent of the cases were excluded from the final statistical analyses, the results of this study may have questionable statistical credibility. Changes in the stimulation index (SI) suggest that the administration of PSK may result in an inhibition of the immunosuppressive activity of cancer patients. The high SI group showed a significantly higher 4 year survival rate than the low SI group.
Similar content being viewed by others
References
Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K, Krestin (PSK). Cancer Treatment Reviews 1984; 11: 131–155.
Hojo H, Hashimoto Y. Cytotoxic cells induced in tumor bearing rats by a streptococal preparation (OK-432). Gann 1981; 72: 692–699.
Ishii Y, Yamaoka H, Toh K, Kikuchi K. Inhibition of tumor growthin vivo andin vitro by macrophages from rats treated with a streptococal preparation, OK-432. Gann 1976; 67: 115–119.
Micksche M, Kokron O, Uchida A. Clinical and immunopharmacological studies with OK-432, a streptococcal preparation. Current concepts in human immunology and cancer immunomodulation. Amsterdam: Elsevier Biomedical Press 1982; 639–645.
Nomoto K, Tsuru S, Awane Y, Kamei H, Ishibiki H, Sekiguchi M, Tamada R, Toge T, Nakajima T. Changes of nonspecific suppressor factors in the serum of gastric cancer patients after surgery and immunochemotherapy. Gan to Kagaku Ryoho (Jpn J Cancer Chemother) 1986; 13: 458–463. (in Japanese)
Hirayama T, Kikuchi S, Mori Y, Kikuchi K, Tamura K, Ishida N. Serum immunosuppressive acidic protein and carcinoembryonic antigen in patients with cancer. Gan to Kagaku Ryoho (Jpn J Cancer Chemother) 1980; 7: 1076–1084. (in Japanese)
Japanese Research Society for Gastric Cancer. The general rules for gastric cancer study in surgery and pathology. Jpn J Surg 1975; 11: 127–145.
Tukey JW. Exploratory Date Analysis. Massachusetts: Addison-Wesley 1976; 27–57.
Simon R, Wittes RE. Methodologic guide lines for reports of clinical trials. Cancer Treatment Reports 1985; 69: 1–3.
Matsunaga K, Morita I, Oguchi Y, Fujii T, Yoshikumi C, Nomoto K. Restoration of immunologic responsiveness by PSK in tumor-bearing animals. Gan to Kagaku Ryoho (Jpn J Cancer Chemother) 1986; 13: 3468–3475. (in Japanese)
Fujimoto S, Greene MI, Sehon AH. Regulation of the immune response to tumor antigens. J Immunol 1976; 116: 800–806.
Toge T, Yanagawa E, Nakanishi K, Yamada Y, Hattori T. Concanavalin A-activated suppressor cell activity in gastric cancer patients. Gann 1980; 71: 784–789.
Toge T, Hamamoto S, Itagaki E, Yajima K, Tanada M, Nakane H, Kohno H, Nakanishi K, Hattori T. Concanavalin A-induced and spontaneous suppressor cell activities in peripheral blood lymphocytes spleen cells from gastric cancer patients. Cancer 1983; 52: 1624–1631.
Kataoka T, Oh-hashi F, Suppressor macrophages in tumor-bearing mice and their selective inhibition by 6-mercaptopurine. Cancer Res 1985; 45: 2139–2144.
Toge T, Ikeda H, Senou N, Niimoto M, Hattori T. Lymphocyte responsiveness to Phytohemagglutinin (PHA) and serum inhibitory effect in patients with gastric cancer. Jpn J Surg 1976; 6: 157–163.
Toge T, Nagasua Y, Nakao H, Ikeda H, Hattori T. Lymphocyte responsiveness to Phytohemagglutinin and its modification by serum inhibitor in breast cancer patients. Gann 1979; 70: 245–248.
Urushizaki I, Ishitani K, Nagai T, Gocho Y, Koyama R. Immunosuppressive factors in serum of patients with gastric carcinoma. Gann 1977; 68: 413–421.
Glasgow AH, Nimberg RB, Menzoian JO, Saporoschetz I, Cooperband SR, Schmid K, Mannick JA. Association of energy with an immunosuppressive peptide fraction in the serum of patients with cancer. New England J Medicine 1974; 291: 1263–1267.
Motoki H, Kurokawa T, Shiraishi H, Kitame F, Ono Y, Ishida N. Purification of an immunosuppressive principle from Ehrlich carcinoma ascites. Gann 1975; 66: 569–572.
Yamazaki H, Nitta K, Umezawa H. Immunosuppression induced with cell-free fluid of Ehrlich carcinoma ascites and its fractions. Gann 1973; 64: 83–92.
Namba M, Ogura T, Hirao F, Yamamura Y. Immunosuppressive activity of the basic protein from tumor tissue. Gann 1977; 68: 751–756.
Tsuru S, Nomoto K, Taniguchi M, Kitani H, Watanabe M, Zinnaka Y. Depression of macrophage function and T-cell-mediated immunity to listeria infection in tumor-bearing mice and its prevention by PSK. Cancer Immunol Immunother 1984; 18: 160–163.
Nomoto K, Ando T, Matsunaga K, Oguchi Y, Fujii T, Nohara M, Morita I, Yagihashi Y, Saito K, Iijima H, Yoshikumi C. Effect of PSK (Krestin) on the resistance to listeria infection in tumor-bearing mice. Recent Advances in Chemotherapy, Anticancer Section 2. Tokyo: Univ Tokyo Press 1985; 872–873.
Matsunaga K, Morita I, Oguchi Y, Fujii T, Yoshikumi C, Nomoto K. Restoration of depressed immune responses by PSK in C3H/He mice bearing syngeneic X5563 tumor. Gan to Kagaku Ryoho (Jpn J Cancer Chemother) 1986; 13: 3453–3460. (in Japanese)
Kikuchi S, Hirayama T, Tateda A, Aneha Y, Kikuchi K, Tamura K, Matsuda Y, Kitane F, Ishida N. Clinical evaluation of the serum level of immunosuppressive acidic protein in pre- and postoperation cancer patients. Gan to Kagaku Ryoho (Jpn J Cancer Chemother) 1979; 6: 289–294. (in Japanese)
Tamura K, Shibata Y, Matsuda Y, Ishida N. Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients. Cancer Research 1981; 41: 3244–3252.
Notsuka T. The restoration effect of PSK on the postoperative immunosuppression in patients with gastric cancer. Fukuoka Igakukai Zasshi (Fukuoka Acta Medica) 1985; 76: 478–488. (in Japanese).
Author information
Authors and Affiliations
Additional information
The Cooperative Project No. 1 of the Japanese Foundation for Multidisciplinary Treatment of Cancer
Rights and permissions
About this article
Cite this article
Hattori, T., Nakajima, T., Nakazato, H. et al. Postoperative adjuvant immunochemotherapy with mitomycin C, tegafur, PSK and/or OK-432 for gastric cancer, with special reference to the change in stimulation index after gastrectomy. The Japanese Journal of Surgery 20, 127–136 (1990). https://doi.org/10.1007/BF02470759
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02470759